The Neurotrophic Factor market is a subset of the Central Nervous System Drugs market, which focuses on treatments for neurological disorders. Neurotrophic Factors are proteins that promote the growth and survival of neurons, and are used to treat a variety of neurological conditions, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Neurotrophic Factors are typically administered through injections, and can be used to replace lost or damaged neurons, or to stimulate the growth of new neurons. The Neurotrophic Factor market is highly competitive, with a number of companies developing and marketing treatments. Companies in the market include Biogen, Novartis, Merck, and Pfizer. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
